Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 6
2023 4
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapy.
Galvez NMS, Cao Y, Nitido AD, Deal CE, Boutros CL, MacDonald SW, Albrecht YES, Lam EC, Sheehan ML, Parsons D, Lin AZ, Deymier MJ, Brady JM, Moon B, Bullock CB, Tanno S, Pegu A, Chen X, Liu C, Koup RA, Mascola JR, Vrbanac VD, Lingwood D, Balazs AB. Galvez NMS, et al. Among authors: balazs ab, sheehan ml. bioRxiv [Preprint]. 2024 Jul 13:2024.07.11.603156. doi: 10.1101/2024.07.11.603156. bioRxiv. 2024. PMID: 39026699 Free PMC article. Preprint.
Immune Signatures of SARS-CoV-2 Infection Resolution in Human Lung Tissues.
Kenney D, O'Connell AK, Tseng AE, Turcinovic J, Sheehan ML, Nitido AD, Montanaro P, Gertje HP, Ericsson M, Connor JH, Vrbanac V, Crossland NA, Harly C, Balazs AB, Douam F. Kenney D, et al. Among authors: balazs ab, sheehan ml. bioRxiv [Preprint]. 2024 Dec 23:2024.03.08.583965. doi: 10.1101/2024.03.08.583965. bioRxiv. 2024. PMID: 38496468 Free PMC article. Preprint.
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children.
Bartsch YC, Chen JW, Kang J, Burns MD, St Denis KJ, Sheehan ML, Davis JP, Edlow AG, Balazs AB, Yonker LM, Alter G. Bartsch YC, et al. Among authors: balazs ab, sheehan ml. NPJ Vaccines. 2022 Dec 3;7(1):158. doi: 10.1038/s41541-022-00575-w. NPJ Vaccines. 2022. PMID: 36463314 Free PMC article.
Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design.
Hauser BM, Feldman J, Sangesland M, Ronsard L, St Denis KJ, Sheehan ML, Cao Y, Boucau J, Windsor IW, Cheng AH, Vu ML, Cardoso MR, Kannegieter T, Balazs AB, Lingwood D, Garcia-Beltran WF, Schmidt AG. Hauser BM, et al. Among authors: balazs ab, sheehan ml. Cell Rep Med. 2022 Dec 20;3(12):100834. doi: 10.1016/j.xcrm.2022.100834. Epub 2022 Nov 15. Cell Rep Med. 2022. PMID: 36423634 Free PMC article.
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity.
Roederer AL, Cao Y, St Denis K, Sheehan ML, Li CJ, Lam EC, Gregory DJ, Poznansky MC, Iafrate AJ, Canaday DH, Gravenstein S, Garcia-Beltran WF, Balazs AB. Roederer AL, et al. Among authors: balazs ab, sheehan ml. Cell Rep Med. 2024 Dec 17;5(12):101850. doi: 10.1016/j.xcrm.2024.101850. Epub 2024 Dec 9. Cell Rep Med. 2024. PMID: 39657661 Free PMC article.
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity.
Roederer AL, Cao Y, Denis KS, Sheehan ML, Li CJ, Lam EC, Gregory DJ, Poznansky MC, Iafrate AJ, Canaday DH, Gravenstein S, Garcia-Beltran WF, Balazs AB. Roederer AL, et al. Among authors: balazs ab, sheehan ml. medRxiv [Preprint]. 2024 Mar 7:2024.03.05.24303815. doi: 10.1101/2024.03.05.24303815. medRxiv. 2024. Update in: Cell Rep Med. 2024 Dec 17;5(12):101850. doi: 10.1016/j.xcrm.2024.101850. PMID: 38496628 Free PMC article. Updated. Preprint.
Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children.
Burns MD, Boribong BP, Bartsch YC, Loiselle M, St Denis KJ, Sheehan ML, Chen JW, Davis JP, Lima R, Edlow AG, Fasano A, Balazs AB, Alter G, Yonker LM. Burns MD, et al. Among authors: balazs ab, sheehan ml. Vaccines (Basel). 2022 Mar 23;10(4):492. doi: 10.3390/vaccines10040492. Vaccines (Basel). 2022. PMID: 35455241 Free PMC article.
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J, Roederer AL, Gregory DJ, Poznansky MC, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB. Garcia-Beltran WF, et al. Among authors: balazs ab, sheehan ml. Cell. 2022 Feb 3;185(3):457-466.e4. doi: 10.1016/j.cell.2021.12.033. Epub 2022 Jan 6. Cell. 2022. PMID: 34995482 Free PMC article.
Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentation.
Hauser BM, Sangesland M, Lam EC, Denis KJS, Sheehan ML, Vu ML, Cheng AH, Balazs AB, Lingwood D, Schmidt AG. Hauser BM, et al. Among authors: balazs ab, sheehan ml. bioRxiv [Preprint]. 2023 Aug 22:2023.08.21.554179. doi: 10.1101/2023.08.21.554179. bioRxiv. 2023. Update in: ACS Infect Dis. 2024 Feb 9;10(2):553-561. doi: 10.1021/acsinfecdis.3c00483. PMID: 37662405 Free PMC article. Updated. Preprint.
Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms.
Atyeo CG, Shook LL, Brigida S, De Guzman RM, Demidkin S, Muir C, Akinwunmi B, Baez AM, Sheehan ML, McSweeney E, Burns MD, Nayak R, Kumar MK, Patel CD, Fialkowski A, Cvrk D, Goldfarb IT, Yonker LM, Fasano A, Balazs AB, Elovitz MA, Gray KJ, Alter G, Edlow AG. Atyeo CG, et al. Among authors: balazs ab, sheehan ml. Nat Commun. 2022 Jun 28;13(1):3571. doi: 10.1038/s41467-022-31169-8. Nat Commun. 2022. PMID: 35764643 Free PMC article.
18 results